Tag - COCH

Developments

Envoy reports improvement in speech perception in trial of cochlear implant

Envoy Medical (NASDAQ: COCH) has announced positive 12-month data from the first ten participants in Stage 1 of its pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant...

July 14, 2026

Developments

Envoy expands IP portfolio with new patents in fully implanted hearing technology

Envoy Medical (NASDAQ: COCH) has announced the issuance of multiple patents across Australia and Europe, as well as the upcoming grant of an additional European patent, further expanding the company’s intellectual...

May 20, 2026

Developments

FDA approves launch of clinical study for Envoy’s breakthrough implanted hearing device

Envoy Medical (NASDAQ:COCH) has announced that the FDA has approved its Investigational Device Exemption application for the pivotal study of its Acclaim fully implanted cochlear implant. The company asserts that the...

November 1, 2024

Tag - COCH

Envoy reports improvement in speech perception in trial of cochlear implant

Envoy expands IP portfolio with new patents in fully implanted hearing technology

FDA approves launch of clinical study for Envoy’s breakthrough implanted hearing device

Subscribe